Cited by 25Dementia and Cognitive Impairment ResearchAdvanced Neuroimaging Techniques and ApplicationsAlzheimer's disease research and treatments

White Matter Alterations in Cognitively Normal apoE ɛ2 Carriers: Insight into Alzheimer Resistance?

Open access
Chiang, G.C., Zhan, W., Schuff, N., Weiner, M.W.·2012·American Journal of Neuroradiology

Abstract

BACKGROUND AND PURPOSE: The basis for decreased vulnerability to AD among apoE ε2 carriers is unknown. The purpose of this study was to use diffusion tensor imaging to detect possible differences in white matter integrity between cognitively normal elderly apoE ε2 carriers and apoE ε3/ε3 controls. MATERIALS AND METHODS: Thirty-nine cognitively normal elderly individuals (19 heterozygous carriers of the apoE ε2 allele, 20 apoE ε3/ε3 subjects as controls) underwent diffusion tensor MR imaging on a 4T scanner. Fractional anisotropy, MD, and axial and radial diffusivity were compared using a ROI approach. In addition, an exploratory whole-brain analysis of fractional anisotropy between the 2 groups was undertaken using TBSS. RESULTS: apoE ε2 carriers had higher FA in the posterior cingulate white matter (P = .01) and anterior corpus callosum (P = .005) than apoE ε3/ε3 controls, secondary to lower radial diffusivity. No significant differences in the FA of the posterior corpus callosum, anterior cingulate white matter, or parahippocampal white matter were seen. Whole-brain TBSS analysis detected regions of higher FA in the apoE ε2 group in the superior longitudinal fasciculus, right thalamus, and the bilateral anterior limbs of the internal capsule, in addition to the posterior cingulum and corpus callosum (P < .005). There were no regions in which the apoE ε3/ε3 group had higher FA. CONCLUSIONS: apoE ε2 carriers harbor more robust white matter integrity that may be associated with decreased vulnerability to developing AD. This provides further evidence that regional DTI metrics may serve as early imaging biomarkers of AD risk.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3174/ajnr.a2984

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chiang, G. C., Zhan, W., Schuff, N., & Weiner, M. W.
Affiliations
San Francisco VA Medical Center (US)
Venue
American Journal of Neuroradiology
Published
2012-03-01
Volume
33
Issue
7
Pages
1392-1397
ISSN
  • 0195-6108 (ISSN-L)
  • 1936-959X
OpenAlex
W2100440179
Cited by
25
References
48
Citations by year
2024: 4 · 2023: 1 · 2022: 2 · 2020: 3 · 2019: 1 · 2017: 1 · 2016: 6 · 2015: 2 · 2014: 2 · 2013: 3
FWCI
1.59
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • American Journal of Neuroradiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
Funders
  • U.S. Department of Defense (U01 AG024904)
  • Michael J. Fox Foundation for Parkinson's Research
  • Eli Lilly and Company
  • Pfizer
  • Biogen
  • Synarc
  • TauRx Pharmaceuticals
  • Bayer HealthCare
  • Irish Research Council
  • Eisai
  • Servier
  • Ipsen
  • National Institutes of Health (5u01ag024904-10, U01-AG024904)
  • Genentech
  • Allergan
  • National Institute on Aging (U01-AG-024904, R01AG010897, P01AG012435, P01AG019724, P50AG023501)
  • National Institute of Neurological Disorders and Stroke (R01NS031966)
  • National Institute of Biomedical Imaging and Bioengineering (T32EB001631)
  • National Center for Research Resources (U24RR021992, P41RR023953)
  • Daiichi Sankyo Europe
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced Neuroimaging Techniques and Applications
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
APOE ε2, white matter integrity, fractional anisotropy, radial diffusivity, cognitively normal elderly, corpus callosum, superior longitudinal fasciculus, thalamus, internal capsule, diffusion tensor imaging
MeSH terms
Aged, Alzheimer Disease, Brain, Cognition Disorders, Female, Heterozygote, Humans, Male, Nerve Fibers, Myelinated, Sensitivity and Specificity, Reproducibility of Results, Apolipoprotein E2, Diffusion Tensor Imaging, Disease Resistance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review